Application no. and date | 13764974.5 (espacenet) (Federated) (European Patent Register), 20130314 | Patent/reg. no. and date | DK/EP 2827710, 20191120 | Publication date | 20150128 | Priority no. and date | US 201261612676 P, 20120319, US 201261707142 P, 20120928 | EP pub. no. and date |
EP 2827710 20150128 | Effective date | | Applicant/owner | Napp Pharmaceutical Group Limited, Unit 191 Cambridge Science Park, Milton Road, CB4 0GW Cambridge, GB | Applicant ref. no. | P70798DK01 | Inventor | RADHAKRISHNAN, Balasingam, 209 Faison Road
Chapel Hill, NC 27517, US, POLOWY, Karen, 5504 Maple Ridge Road
Raleigh, NC 27609, US, VAIDYA, Anuradha, 2700 Kinsley Place
Raleigh, NC 27616, US, JAMES, Kenneth, Duke, 3908 Long Meadow Drive
Mebane, NC 27302, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A01N 37/18 (2006.01) , A61K 38/12 (2006.01) , A61K 47/10 (2017.01) , A61K 47/12 (2006.01) , A61K 47/18 (2017.01) , A61K 47/26 (2006.01) , A61K 9/00 (2006.01) , A61K 9/08 (2006.01) , A61P 31/10 (2006.01) | Title | DOSERINGSSKEMA FOR ECHINOCANDIN-KLASSE-FORBINDELSER | Int. application no. | US2013031678 | Int. publication no. | WO2013142279 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|